Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Cellectar Biosciences, Inc.

NASDAQ: CLRBZHealthcare / Biotechnology / -
0.1000-0.0100-9.09%Vol 3001Y Perf -79.02%
Jan 16th, 2019 11:18
BID0.0700 ASK0.1000
Open0.1000 Previous Close0.1100
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)- 
Earnings Rating
Neutral
Price Range Ratio 52wk %
10.91 
Earnings Date
-

Today's Price Range

0.10000.1000

 

52wk Range

0.04000.5900

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-16.67%
3 Months
-16.67%
6 Months
-58.33%
1 Year
-79.02%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
CLRBZ0.1000-0.0100-9.09
AAPL154.941.87001.22
GOOG1 080.973.82000.35
MSFT105.380.37000.35
XOM71.64-0.0300-0.04
WFC48.941.27002.66
JNJ128.04-1.3200-1.02
FB147.54-1.4100-0.95
GE8.980.25002.86
JPM102.500.82000.81
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
-
Current Ratio
-
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio -
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
-
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-
Cash Flow Per Share
-
Price to Tangible Book
-
Book Value per Share
-
Enterprise Value (in ths.)
-
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-
ROE last 12 Months
-
Return on Assets (5Y Avg)
-
ROA last 12 Months
-
Return on Capital (5Y Avg)
-
ROC last 12 Months
-
Return on invested Capital Q
-
Return on invested Capital Y
-
Assets Turnover
-
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
-
Revenue per Share
-
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume300
Shares Outstanding (in ths.)0
Trades Count0
Dollar Volume0
Avg. Volume2 500
Avg. Weekly Volume7 920
Avg. Monthly Volume14 405
Avg. Quarterly Volume12 570

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

68%32%

Bearish Bullish

59%41%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News